New shot shrinks skin cancer before surgery in early trial
Disease control
Ongoing
This study tests an experimental drug called BO-112, injected directly into basal cell skin cancer tumors before they are surgically removed. The goal is to see if the drug is safe and helps shrink or eliminate the cancer. About 60 adults with low- or high-risk basal cell carcino…
Phase: PHASE2 • Sponsor: Highlight Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC